Jump to navigation
THE RACGP has voiced concern over the speed of the rollout of new generation anticoagulants and the associated “pressure” for subsidy.
If you have an account select Login. If you are new to Medical Observer select Join.
News and features from Medical Observer's writers and editors.
More articles by this author >
Australian Doctor Group is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.